{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(63)"],"submitter":["Vidula N"],"journal":["Oncotarget"],"pagination":["106167-106168"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5739720"],"repository":["biostudies-literature"],"pubmed_title":["Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology."],"pmcid":["PMC5739720"],"pubmed_authors":["Vidula N","Bardia A"],"additional_accession":[]},"is_claimable":false,"name":"Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology.","description":null,"dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Dec","modification":"2025-04-04T12:32:13.433Z","creation":"2025-04-04T12:32:13.433Z"},"accession":"S-EPMC5739720","cross_references":{"pubmed":["29290935"],"doi":["10.18632/oncotarget.22580"]}}